Blastocystis and its pathogenic potential: Latest aspects

Reviews and Research in Medical Microbiology

Volumn 19, Issue 4, 2008, Pages 87-97

  Vassalos, Constantine M ^a,b,c   Vakalis, Nicholas ^a   Papadopoulou, Chryssanthy ^b  

^a NATIONAL SCHOOL OF PUBLIC HEALTH   (Greece)

^b UNIVERSITY OF IOANNINA   (Greece)

^c UNIVERSITY OF IOANNINA   (Greece)

Author keywords

Amoeboid forms; Blastocystis; Irritable bowel syndrome like; Metronidazole; Pathogenic potential; Resistance; Subtype 3; Utricaria; Virulence

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN E; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN G2; INTERLEUKIN 8; METRONIDAZOLE; NITAZOXANIDE; ORNIDAZOLE; PAROMOMYCIN; PLACEBO; SULFAMETHOXAZOLE; TRIMETHOPRIM; VIRULENCE FACTOR;

ABDOMINAL DISCOMFORT; ABDOMINAL PAIN; ANTIBIOTIC RESISTANCE; BLASTOCYSTIS; BLASTOCYSTOSIS; CONSTIPATION; DEPRESSION; DIARRHEA; DIENTAMOEBA; DISEASE TRANSMISSION; DRUG SENSITIVITY; DRUG TOLERABILITY; ENTAMOEBA; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHIL COUNT; FATIGUE; FECES; FECES ANALYSIS; FLATULENCE; GENETIC VARIABILITY; GENOTYPE; HEADACHE; HOST; HUMAN; IMMUNOCOMPROMISED PATIENT; INFECTION RISK; INTESTINE PARASITE; IRRITABLE COLON; LIFE CYCLE; MICROBIAL MORPHOLOGY; MICROSCOPY; MIXED INFECTION; NAUSEA; NONHUMAN; PATHOGENESIS; PATHOGENICITY; PATIENT COMPLIANCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PRURITUS; REVIEW; SKIN DISEASE; SKIN SWELLING; STAINING; SURFACE PROPERTY; TH2 CELL; TREATMENT FAILURE; URTICARIA;

EID: 68149110150     PISSN: 0954139X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MRM.0b013e32832d87ec     Document Type: Review

References (77)

1. Stensvold CR, Suresh GK, Tan KSW, Thompson RCA, Traub RJ, Viscogliosi E, et al. Terminology for Blastocystis subtypes: a consensus. Trends Parasitol 2007; 23:93-96.
2. Stensvold CR, Alfellani MA, Nørskov-Lauritsen S, Prip K, Victory EL, Maddox C, et al. Subtype distribution of Blastocystis isolates from synanthropic and zoo animals and identification of a new subtype. Int J Parasitol 2008; 39:473-479; doi:10.1016/j.ij-para.2008.07. 006.
3. Tan KS. New insights on classification, identification, and clinical relevance of Blastocystis spp. Clin Microbiol Rev 2008; 21:639-665.
4. Stenzel DJ, Boreham PFL. Blastocystis hominis revisited. Clin Microbiol Rev 1996; 4:563-584.
5. Tan TC, Suresh KG. Amoeboid form of Blastocystis hominis: a detailed ultrastructural insight. Parasitol Res 2006; 99:737- 742.
6. Tan TC, Suresh KG. Evidence of plasmotomy in Blastocystis hominis. Parasitol Res 2007; 101:1521-1525.
7. Hirata T, Nakamura H, Kinjo N, HokamaA, Kinjo F,Yamane N, Gujita J. Prevalence of Blastocystis hominis and Strongyloides stercolaris infection in Okinawa, Japan. Parasitol Res 2007; 101:1717-1719.
8. Yoshikawa H, Abe N, Iwasawa M, Kitano S, Nagano I, Wu Z, Takahashi Y. Genomic analysis of Blastocystis hominis strains isolated from two long-term healthcare facilities. J Clin Microbiol 2000; 38:1324-1330.
9. Stensvold CR, Arendrup MC, Jespersgaard C, Mølbak K, Nielsen HV. Detecting Blastocystis using parasitologic and DNA-based methods: a comparative study. Diagn Microbiol Infect Dis 2007; 59:303-307.
10. Tan KSW, Singh M, Yap Eh. Recent advances in Blastocystis hominis research: hot spots in terra incognita. Int J Parasritol 2002; 32:789-804.
11. Ö zyurt M, Kurt O, Mølbak K, Nielsen HV, Haznedaroglu T, Stensvold CR. Molecular epidemiology of Blastocystis infections in Turkey. Parasitol Int2008; 57:300-306.
12. Dogruman-Al F, Dagci H, Yoshikawa H, Kurt Ö , Demirel M. A possible link between subtype 2 and asymptomatic infections of Blastocystis hominis. Parasitol Res 2008; 103:685-689.
13. Hussein EM, Hussein AM, Eida MM, Atwa MM. Pathophysiological variability of differentgenotypes of human Blastocystis hominis Egyptian isolates in experimentally infected rats. Parasitol Res 2008; 102:853-860.
14. Jones MS, Whipps CM, Ganac RD, Hudson NR, Boroom K. Association of Blastocystis subtype 3 and 1 with patients from an Oregon community presenting with chronic gastrointestinal illness. Parasitol Res 2008; 104:341-345; doi: 10.1007/s00436-008-1198-7.
15. Kaneda Y, Horiki N, Cheng X-J, Fujita Y, Maruyama M, Tachibana H. Ribodemes of Blastocystis hominis isolated in Japan. Am J Trop Med Hyg 2001; 65:393-396.
16. Katsarou-Katsari A, Vassalos CM, Tzanetou K, Spanakos G, Papadopoulou C, Vakalis N. Acute urticaria associated with amoeboid forms of Blastocystis sp. subtype 3. Acta Derm Venereol 2008; 88:80-81.
17. Stensvold CR, Arendrup MC, Nielsen HV, Bada A, Thorsen S. Symptomatic infection with Blastocystis sp. subtype 8 successfully treated with trimethoprim-sulfamethoxazole. Ann Trop Med Parasitol 2008; 102:271-274.
18. Tan TC, Suresh KG, Smith HV. Phenotypic and genotypic characterisation of Blastocystis hominis isolates implicates subtype 3 as a subtype with pathogenic potential. Parasitol Res 2008; 104:85-93.
19. Yan Y, Su S, Lai R, Liao H, Ye J, Li X, et al. Genetic variability of Blastocystis hominis isolates in China. Parasitol Res 2000; 99:597-601.
20. Te-Li C, Che-Chang C, Hsin-Pai C, Chang-Phone F, Chih-Pei L, Wan-Leong C, Cheng-Yi L. Clinical significance and endoscopic findings associated with Blastocystis hominis in healthy adults. Am J Trop Med Hyg 2003; 68:213-216.
21. Puthia MK, Lu J, Tan KS. Blastocystis ratti contains cysteine proteases that mediate interleukin-8 response from human intestinal epithelial cells in an NF-kappaB-dependent manner. Eukaryot Cell 2008; 7:435-443.
22. Mirza H, Tan KS. Blastocystis exhibits inter- and intra-subtype variation in cysteine protease activity. Parasitol Res 2008; 104:355-361; doi: 10.1007/s00436-008-1203-1.
23. Clark CG. Entamoeba histolytica and Entamoeba dispar, the nonidentical twins. In: Sterling CR, Adam RD, editors. The pathogenic enteric protozoa: Giardia, Entamoeba, Cryptospor-idium and Cyclospora. Boston, Massachusetts, USA: Kluwer Academic Publishers; 2004. pp. 15-26.
24. Kaneda Y, Horiki N, Cheng X-J, Tachibana H, Tsutsumi Y. Serologic response to Blastocystis hominis infection in asymptomatic individuals. Tokai J Exp Clin Med 2000; 25:41-56.
25. Wang K-X, Li C-P, Wang J, Cui Y-B. Epidemiological survey of Blastocystis hominis in Huainan City, Anhui Province, China. World J Gastroenterol 2002; 8:928-932.
26. Giacometti A, Cirioni O, Antonicelli L, D'Amato G, Silvestri C, Del Prete MS, Scalise G. Prevalence of intestinal parasites among individuals with allergic skin diseases. J Parasitol 2003; 89:490-492.
27. Staumont-Sallé D, Dombrowicz D, Capron M, Delaporte E. Eosinophils and urticaria. Clin Rev Allergy Immunol 2006; 30:13-18.
28. Valsecchi R, Leghissa P, Greco V. Cutaneous lesions in Blastocystis hominis infection. Acta Derm Venereol 2004; 84:322-323.
29. Boreham PFL, Stenzel DJ. Blastocystis in humans and animals: morphology, biology and epizootiology. Adv Parasitol 1993; 31:1-70.
30. Gassama A, Sow PS, Fall F, Camara P, Philippe H, Guèye-N'diaye A, et al. Ordinary and opportunistic enteropathogens associated in Senegalese adults in relation to human immunodeficiency virus serostatus. Int J Infect Dis 2001; 5:192-198.
31. Flórez AC, GarcÍa DA, Mincada L, Beltrán M. Prevalence of microsporidia and other intestinal parasites with HIV infection, Bogota, 2001. Biomedica 2003; 23:274-282.
32. Hayashi M, Inamori M, Goto K, Akiyama T, Fujita K, Ikeda I, et al. Blastocystis hominis infection in patient with regular dialysis. J Gastroenterol 2006; 41:605-606.
33. Taşova Y, Şahin B, Koltaş S, Paydaş S. Clinical significance and frequency of Blastocystis hominis in Turkish patients with hematological malignancy. Acta Med Okayama 2000; 54:133-136.
34. Ghosh K, Ayyaril M, Nirmala V. Acute GVHD involving the gastrointestinal tract and infestation with Blastocystis hominis in a patient with chronic myeloid leukaemia following allo-geneic bone marrow transplantation. Bone Marrow Transplant 1998; 22:1115-1117.
35. Lucía JF, Aguilar C, Betran A. Blastocystis hominis colitis in a haemophilic patient as a cause of lower gastrointestinal bleeding. Haemophilia 2007; 13:224-225.
36. Levy Y, George J, Shoenfeld Y. Severe Blastocystis hominis in an elderly man. J Infect 1996; 33:57-59.
37. Sheehan JP, Ulchaker MM. Blastocystis hominis treatable cause of diabetic diarrhea. Diabetes Care 1990; 13:906-907.
38. Doyle PW, Helgason MM, Mathas RG, Proctor EM. Epidemiology and pathogenicity of Blastocystis hominis. J Clin Microbiol 1990; 28:116-121.
39. Yao FR, Qiao JY, Zhao Y, Zhang X, Yang JH, Li XQ. Experimental infection of mice with Blastocystis hominis. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi 2005; 23:444-448.
40. Zierdt CH, Tan HK. Ultrastructure and light microscope appearance of Blastocystis hominis in a patient with enteric disease. Z Parasitenk 1976; 50:277-283.
41. Nagler J, Brown M, Soave R. Blastocystis in inflammatory bowel disease. J Clin Gastroenterol 1993; 16:109-112.
42. Stark D, van Hal S, Marriott D, Ellis J, Harkness J. Irritable bowel syndrome: a review on the role of intestinal protozoa and the importance of their detection and diagnosis. Int J Parasitol 2007; 37:11-20.
43. Giacometti A, Cirioni O, Fiorentini A, Fortuna M, Scalise G. Irritable bowel syndrome in patients with Blastocystis hominis infection. Eur J Clin Microbiol Infect Dis 1999; 18:436-439.
44. Sheehan DJ, Raucher BG, McKitrick JC. Association of Blastocystis hominis with signs and symptoms of human disease. J Clin Microbiol 1986; 4:548-550.
45. Stensvold CR, Arendrup MC, Mølbak K, Nielsen HV. The prevalence of Dientamoeba fragilis in patients with suspected enteroparasitic disease in a metropolitan area in Denmark. Clin Microbiol Infect 2007; 13:813-816.
46. Windsor JJ, Macfarlane L. Irritable bowel syndrome: the need to exclude Dientamoeba fragilis. Am J Trop Med Hyg 2005; 72:501.
47. Yavasoglu I, Kadikoylu G, Uysal H, Ertug S, Bolaman Z. Is Blastocystis hominis a new etiologic factor or a coincidence in iron deficiency anemia? Eur J Haematol 2008; 8:47-50.
48. Kulik RA, Falavigna DL, Nishi L, Araujo SM. Blastocystis sp. and other intestinal parasites in hemodialysis patients. Braz J Infect Dis 2008; 12:338-341.
49. Lanuza MD, Carbajal JA, Villar J, Borrás R. Description of an improved methodfor B. hominis culture and axenization. Parasitol Res 1997; 83:60-63.
50. Galván-Moroyoqui JM, Del Carmen Domínguez-Robles M, Franco E, Meza I. The Interplay between Entamoeba and enteropathogenic bacteria modulates epithelial cell damage. PLoS Negl Trop Dis 2008; 2:e266.
51. Biedermann T, Hartmann K, Sing A, Przybilla B. Hypersensitivity to nonsteroidal anti-inflammatory drugs and chronic urticaria curedby treatment of Blastocystis hominis infection. Br J Dermatol 2002; 146:1113-1114.
52. Cassano N, Scopio BM, Loviglio MC, Vena GA. Remission of delayed pressure urticaria after eradication of Blastocystis hominis. Acta Derm Veneorol 2005; 85:357-358.
53. Gupta R, Parsi K. Chronic urticaria due to Blastocystis hominis. Australas J Dermatol 2006; 47:117-119.
54. Kick G, Rueff F, Przybilla B. Palmoplantar pruritus subsiding after Blastocystis hominis eradication. Acta Derm Venereol 2002; 82:60.
55. Micheloud D, Jensen J, Fernandez-Cruz E, Carbone J. Chronic angioedema and blastocystis hominis infection. Rev Gastroenterol Peru 2007; 27:191-193.
56. Pasqui AL, Savini E, Saletti M, Guzzo C, Puccetti L, Auteri A. Chronic urticaria andBlastocystis hominis infection. A case report. Eur Rev Med Pharmacol Sci 2004;8:117-120.
57. Armentia A, Méndez J, Gómez A, Sanchís E, Fernández A, de la Fuente R, Sánchez P. Urticaria by Blastocystis hominis. Successful treatment with paromomycin. Allergol Immunopathol (Madr) 1993; 21:149-151.
58. Vassalos CM, Papadopoulou C, Vakalis N. Blastocystosis: emerging or re-emerging zoonosis? Vet Ital 2008; 44:679-684.
59. Lee MG, Rawlins SC, Didier M, DeCeulaer K. Infective arthritis due to Blastocystis hominis. Ann Rheum Dis 1990; 49:192-193.
60. Lakhanpal S, Cohen SB, Fleischmann RM. Reactive arthritis from Blastocystis hominis. Arthritis Rheum 1991; 34:251-253.
61. Jelinek T, Peyerl G, Löscher T, von Sonnenburg F, Nothdurft HD. The role of Blastocystis hominis as a possible intestinal pathogen in travellers. J Infect 1997; 35:63-66.
62. Hu KC, Lin CC, Wang TE, Liu CY, Chen MJ, Chang WH. Amoebic liver abscess or is it? Gut 2008; 57:627; 683.
63. Qadri SM, al-Okaili GA, al-Dayel F. Clinical significance of Blastocystis hominis. J Clin Microbiol 1989; 27:2407-2409.
64. Boorom KF. Is this recently characterized gastrointestinal pathogen responsible for rising rates of inflammatory bowel diseases (IBD) and IBD associated autism in Europe and the United States in the 1990s? Med Hypotheses 2007; 69:652- 659.
65. Vdovenko AA, Williams JE. Blastocystis hominis: neutral red supravital staining and its application to in vitro drug sensitivity testing. Parasitol Res 2000; 86:573-581.
66. Su SL, Yan YM, Liao H, Chen GF, Zhang RQ, Xie QJ, et al. Dot enzyme-linked immunosorbent assay for detection of serum antibody to Blastocystis hominis in humans. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi 2007; 25:256-258.
67. Dunn LA, Boreham PFL. The in vitro activity of drugs against Blastocystis hominis. J Antimicrob Chemother 1991; 27:507- 516.
68. Zierdt CH, Swan JC, Hosseini J. In vitro response of Blastocystis hominis to antiprotozoal drugs. J Protozool 1983; 30:332-334.
69. Lantsman Y, Tan KS, Morada M, Yarlett N. Biochemical characterization of a mitochondrial-like organelle from Blastocystis sp. subtype 7. Microbiology 2008; 154 (Pt 9):2757-2766.
70. Nigro L, Larocca L, Massarelli L, Patamia I, Minnitti S, Palermo F, Cacopardo B. A placebo-controlled treatment trial of Blastocystis hominis infection with metronidazole. J Travel Med 2003; 10:128-130.
71. Kaya S, Cetin ES, Aridogan BC, Arikan S, Demirci M. Pathogenicity of Blastocystis hominis, a clinical reevaluation. Turkiye Parazitol Derg 2007; 31:184-187.
72. Ok UZ, Cirit M, Uner A, Ok E, Akcicek F, Basci A, Ozcel MA. Cryptosporidiosis and blastocystosis in renal transplant recipients. Nephron 1997; 75:171-174.
73. Rossignol J-F, Kabil SM, Said M, Samir H, Younis AM. Effect of nitazoxanide in persistent diarrhea and enteritis associated with Blastocystis hominis. Clin Gastroenterol Hepatol 2005; 3:987-991.
74. Díaz E, Mondragon J, Ramirez E, Bernal R. Epidemiology and control of intestinal parasites with nitazoxanide in children in Mexico. Am J Trop Med Hyg 2003; 68:384-385.
75. Ok UZ, Girginkardesler N, Balcioglu C, Ertan P, Pirildar T, Kilimcioglu AA. Effect of trimethoprim-sulfamethaxazole in Blastocystis hominis infection. Am J Gastroenterol 1999; 94:3245-3247.
76. Moghaddam DD, Ghadirian E, Azami M. Blastocystis hominis and the evaluation of efficacy of metronidazole and trimetho-prim/sulfamethoxazole. Parasitol Res 2005; 96:273-275.
77. Eida OM, Hussein EM, Eida AM, El-Moamly AA, Salem AM. Evaluation of the nitric oxide activity against Blastocystis hominis in vitro and in vivo. J Egypt Soc Parasitol 2008; 38:521-536.